SCIENCE GROUP PLC — Major Shareholding Notification 2025

Apr 4, 2025

National Storage Mechanism | Additional information

RNS Number : 6254D

Science Group PLC

04 April 2025

4 April 2025

Science Group plc

(the "Group" or "Science Group")

Increased Shareholding in Ricardo plc

Science Group has further increased its shareholding in Ricardo plc ("Ricardo") to 11,875,242 shares, equivalent to approximately 19.09% of the voting rights. The average cost (including fees) is 235 pence per share. Science Group may or may not increase its shareholding in Ricardo.

Science Group is the second largest shareholder in Ricardo. Science Group's position has been set out in the following announcements:

·    17 March 2025: www.sciencegroup.com/news-detail/response-to-ricardo-plc-17-03-25

·    31 March 2025: www.sciencegroup.com/news-detail/update-on-ricardo-plc

Science Group notes that Ricardo has not yet responded in a substantive manner to the corporate and operational matters raised in those announcements .

- Ends -

For further information:

Science Group plc
Martyn Ratcliffe, Executive Chair	Tel: +44 (0) 1223 875 200
Jon Brett, Finance Director	www.sciencegroup.com
Canaccord Genuity Limited (Nominated Adviser and Joint Broker)
Simon Bridges, Andrew Potts	Tel: +44 (0) 20 7523 8000
MHP
Reg Hoare	Tel: +44 (0) 7831 406117
	[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCFLFVASSIVIIE